Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HEEREMA, Nyla A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 62

  • Page / 3
Export

Selection :

  • and

Cytogenetics in acute leukemiaMROZEK, Krzysztof; HEEREMA, Nyla A; BLOOMFIELD, Clara D et al.Blood reviews. 2004, Vol 18, Num 2, pp 115-136, issn 0268-960X, 22 p.Article

Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximabBYRD, John C; SMITH, Lisa; HACKBARTH, Marcy L et al.Cancer research (Baltimore). 2003, Vol 63, Num 1, pp 36-38, issn 0008-5472, 3 p.Article

Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952BASSAL, Mylène; LA, Mei K; WHITLOCK, James A et al.Pediatric blood & cancer. 2005, Vol 44, Num 1, pp 21-28, issn 1545-5009, 8 p.Article

Periconceptional vitamin use and leukemia risk in children with down syndrome : A children's oncology group studyROSS, Julie A; BLAIR, Cindy K; OLSHAN, Andrew F et al.Cancer. 2005, Vol 104, Num 2, pp 405-410, issn 0008-543X, 6 p.Article

Congenital Abnormalities and Acute Leukemia among Children with Down Syndrome : A Children's Oncology Group StudyLINABERY, Amy M; BLAIR, Cindy K; GAMIS, Alan S et al.Cancer epidemiology, biomarkers & prevention. 2008, Vol 17, Num 10, pp 2572-2577, issn 1055-9965, 6 p.Article

Racial and ethnic differences in survival of children with acute lymphoblastic leukemiaBHATIA, Smita; SATHER, Harland N; HEEREMA, Nyla A et al.Blood. 2002, Vol 100, Num 6, pp 1957-1964, issn 0006-4971, 8 p.Article

Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemiaJAGLOWSKI, Samantha M; RUPPERT, Amy S; ANDRITSOS, Leslie A et al.British journal of haematology. 2012, Vol 159, Num 1, pp 82-87, issn 0007-1048, 6 p.Article

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology GroupMATLOUB, Yousif; BOSTROM, Bruce C; BUCKLEY, Patrick J et al.Blood. 2011, Vol 118, Num 2, pp 243-251, issn 0006-4971, 9 p.Article

Dic(17;18)(p11.2;p11.2) is a recurring abnormality in chronic lymphocytic leukaemia associated with aggressive diseaseWOYACH, Jennifer A; HEEREMA, Nyla A; BYRD, John C et al.British journal of haematology. 2010, Vol 148, Num 5, pp 754-759, issn 0007-1048, 6 p.Article

Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective studyHASLE, Henrik; ALONZO, Todd A; HARBOTT, Jochen et al.Blood. 2007, Vol 109, Num 11, pp 4641-4647, issn 0006-4971, 7 p.Article

Outcome of treatment in children with hypodiploid acute lymphoblastic leukemiaNACHMAN, James B; HEEREMA, Nyla A; SILVERMAN, Lewis B et al.Blood. 2007, Vol 110, Num 4, pp 1112-1115, issn 0006-4971, 4 p.Article

Maternal diet and infant leukemia: The DNA topoisomerase II inhibitor hypothesis: A report from the Children's Oncology GroupSPECTOR, Logan G; YANG XIE; BLAIR, Cindy K et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 3, pp 651-655, issn 1055-9965, 5 p.Article

Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemiaHEEREMA, Nyla A; SATHER, Harland N; GAYNON, Paul S et al.Journal of clinical oncology. 2000, Vol 18, Num 22, pp 3837-3844, issn 0732-183XArticle

Complete Response to Induction Therapy in Patients With Myc-Positive and Double-Hit Non-Hodgkin Lymphoma Is Associated With Prolonged Progression-Free SurvivalCOHEN, Jonathon B; GEYER, Susan M; CHRISTIAN, Beth A et al.Cancer. 2014, Vol 120, Num 11, pp 1677-1685, issn 0008-543X, 9 p.Article

Analysis of the Role of Hematopoietic Stem-Cell Transplantation in Infants With Acute Lymphoblastic Leukemia in First Remission and MLL Gene Rearrangements: A Report From the Children's Oncology GroupDREYER, Zoann E; DINNDORF, Patricia A; WILLMAN, Cheryl L et al.Journal of clinical oncology. 2011, Vol 29, Num 2, pp 214-222, issn 0732-183X, 9 p.Article

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international studyCOENEN, Eva A; RAIMONDI, Susana C; FORESTIER, Erik et al.Blood. 2011, Vol 117, Num 26, pp 7102-7111, issn 0006-4971, 10 p.Article

An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961NELSON, Marilu; PERKINS, Sherrie L; SANGER, Warren G et al.British journal of haematology. 2010, Vol 148, Num 4, pp 600-610, issn 0007-1048, 11 p.Article

Infant leukemia and parental infertility or its treatment: a Children's Oncology Group reportPUUMALA, Susan E; SPECTOR, Logan G; WALL, Melanie M et al.Human reproduction (Oxford. Print). 2010, Vol 25, Num 6, pp 1561-1568, issn 0268-1161, 8 p.Article

Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximabAWAN, Farrukh T; KAY, Neil E; GREVER, Michael R et al.Blood. 2009, Vol 113, Num 3, pp 535-537, issn 0006-4971, 3 p.Article

Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia : a report from the Children's Oncology GroupLANGE, Beverly J; SMITH, Franklin O; WEIMAN, Margie et al.Blood. 2008, Vol 111, Num 3, pp 1044-1053, issn 0006-4971, 10 p.Article

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemiaKAY, Neil E; GEYER, Susan M; HEEREMA, Nyla A et al.Blood. 2007, Vol 109, Num 2, pp 405-411, issn 0006-4971, 7 p.Article

Risk-and response-based classification of childhood B-precursor acute lymphoblastic leukemia : a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)SCHULTZ, Kirk R; JEANETTE PULLEN, D; RAETZ, Elizabeth A et al.Blood. 2007, Vol 109, Num 3, pp 926-935, issn 0006-4971, 10 p.Article

Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid LeukemiaMROZEK, Krzysztof; MARCUCCI, Guido; PETTENATI, Mark J et al.Journal of clinical oncology. 2012, Vol 30, Num 36, pp 4515-4523, issn 0732-183X, 9 p.Article

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AMLPOLLARD, Jessica A; ALONZO, Todd A; WEINSTEIN, Howard J et al.Blood. 2010, Vol 115, Num 12, pp 2372-2379, issn 0006-4971, 8 p.Article

Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemiaGAIKWAD, Amos; RYE, Cassia L; DEVIDAS, Meenakshi et al.British journal of haematology. 2009, Vol 144, Num 6, pp 930-932, issn 0007-1048, 3 p.Article

  • Page / 3